These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 12057923)

  • 1. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
    Woodman SE; Park DS; Cohen AW; Cheung MW; Chandra M; Shirani J; Tang B; Jelicks LA; Kitsis RN; Christ GJ; Factor SM; Tanowitz HB; Lisanti MP
    J Biol Chem; 2002 Oct; 277(41):38988-97. PubMed ID: 12138167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.
    Cohen AW; Park DS; Woodman SE; Williams TM; Chandra M; Shirani J; Pereira de Souza A; Kitsis RN; Russell RG; Weiss LM; Tang B; Jelicks LA; Factor SM; Shtutin V; Tanowitz HB; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Feb; 284(2):C457-74. PubMed ID: 12388077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
    Razani B; Combs TP; Wang XB; Frank PG; Park DS; Russell RG; Li M; Tang B; Jelicks LA; Scherer PE; Lisanti MP
    J Biol Chem; 2002 Mar; 277(10):8635-47. PubMed ID: 11739396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness.
    De Souza AP; Cohen AW; Park DS; Woodman SE; Tang B; Gutstein DE; Factor SM; Tanowitz HB; Lisanti MP; Jelicks LA
    Magn Reson Imaging; 2005 Jan; 23(1):61-8. PubMed ID: 15733789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Caveolin genes: from cell biology to medicine.
    Williams TM; Lisanti MP
    Ann Med; 2004; 36(8):584-95. PubMed ID: 15768830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
    Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.
    Zhao YY; Liu Y; Stan RV; Fan L; Gu Y; Dalton N; Chu PH; Peterson K; Ross J; Chien KR
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11375-80. PubMed ID: 12177436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
    Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The caveolin proteins.
    Williams TM; Lisanti MP
    Genome Biol; 2004; 5(3):214. PubMed ID: 15003112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting rid of caveolins: phenotypes of caveolin-deficient animals.
    Le Lay S; Kurzchalia TV
    Biochim Biophys Acta; 2005 Dec; 1746(3):322-33. PubMed ID: 16019085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.
    Razani B; Wang XB; Engelman JA; Battista M; Lagaud G; Zhang XL; Kneitz B; Hou H; Christ GJ; Edelmann W; Lisanti MP
    Mol Cell Biol; 2002 Apr; 22(7):2329-44. PubMed ID: 11884617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
    Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
    Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins.
    Voldstedlund M; Vinten J; Tranum-Jensen J
    Cell Tissue Res; 2001 Nov; 306(2):265-76. PubMed ID: 11702238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
    Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31).
    Engelman JA; Zhang XL; Galbiati F; Lisanti MP
    FEBS Lett; 1998 Jun; 429(3):330-6. PubMed ID: 9662443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urogenital alterations in aged male caveolin-1 knockout mice.
    Woodman SE; Cheung MW; Tarr M; North AC; Schubert W; Lagaud G; Marks CB; Russell RG; Hassan GS; Factor SM; Christ GJ; Lisanti MP
    J Urol; 2004 Feb; 171(2 Pt 1):950-7. PubMed ID: 14713860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.